Evidence map›Paper›PMID 17296934›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Vasily Vasko, Allan V Espinosa, William Scouten, Huiling He, Herbert Auer, Sandya Liyanarachchi, Alexander Larin, Victoria Savchenko, Gary L Francis, Albert de la Chapelle and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01384669 (Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma), which is not on this map. Cited by 171 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01384669 completednot on this mapstarted 2011, after this paper: background citation

Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis

TypeobservationalSponsorYonsei UniversityRan2011 to 2013Enrolled29ConditionsPapillary Thyroid Microcarcinoma
3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 1 synthesis or guideline pooled it, 309 citations in OpenAlex.

  1. Pooled it
  2. Pathogenesis of Thyroid Cancer with Particular Emphasis on the Role of AnoikisJournal of clinical research in pediatric endocrinology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Expression of CLDN1 and EGFR in PTC.Discover oncology · 2024
    Article
  14. Article
  15. Papillary thyroid carcinoma with invasion of the trachea.Annals of medicine and surgery (2012) · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Vasily VaskoDepartment of Medicine, Arthur G. James Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
Allan V Espinosa
William Scouten
Huiling He
Herbert Auer
Sandya Liyanarachchi
Alexander Larin
Victoria Savchenko
Gary L Francis
Albert de la Chapelle
Motoyasu Saji
Matthew D Ringel
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUniformed Services University of the Health Sciences · USNationwide Children's Hospital · USVirginia Commonwealth University Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Akt Intracellular Localization in Thyroid CancerR01CA102572 · NCI · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2005 to 2009
$1.3M
NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA 16058NCI NIH HHS R01 CA102572NCI NIH HHS R01 CA 102572-02
6 · The paper itself

Abstract

Papillary thyroid carcinomas (PTCs) that invade into local structures are associated with a poor prognosis, but the mechanisms for PTC invasion are incompletely defined, limiting the development of new therapies. To characterize biological processes involved in PTC invasion, we analyzed the gene expression profiles of microscopically dissected intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue by oligonucleotide microarray and performed confirmatory expression and functional studies. In comparison with the central regions of primary PTCs, the invasive fronts overexpressed TGF beta, NFkappaB and integrin pathway members, and regulators of small G proteins and CDC42. Moreover, reduced levels of mRNAs encoding proteins involved in cell-cell adhesion and communication were identified, consistent with epithelial-to-mesenchymal transition (EMT). To confirm that aggressive PTCs were characterized by EMT, 34 additional PTCs were examined for expression of vimentin, a hallmark of EMT. Overexpression of vimentin was associated with PTC invasion and nodal metastasis. Functional, in vitro studies demonstrated that vimentin was required both for the development and maintenance of a mesenchymal morphology and invasiveness in thyroid cancer cells. We conclude that EMT is common in PTC invasion and that vimentin regulates thyroid cancer EMT in vitro.

Indexed as

Gene Expression Regulation, NeoplasticAdenocarcinoma, PapillaryCell NucleusCluster AnalysisEpithelial CellsHumansMesodermNeoplasm InvasivenessNeoplasm ProteinsOligonucleotide Array Sequence AnalysisPhosphorylationProtein TransportRNA, MessengerThyroid NeoplasmsTumor Cells, CulturedVimentinNeoplasm ProteinsRNA, MessengerVimentin

Identifiers

PMID17296934
PMCPMC1815262
OpenAlexW2094880719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.